Once-Daily Nebivolol 5mg Does Not Reduce Airway Patency in Patients with Chronic Obstructive Pulmonary Disease and Arterial Hypertension: A Placebo-Controlled Crossover Study

By dal Negro R.W.   Tognella S.   Pomari C.  

Clinical Drug Investigation, Vol. 22, Iss. 6, 2002-06 ,pp. : 361-367

Adis International

Access to resources Recommend Favorite

Efficacy and Safety of 24 Weeks of Therapy with Bendroflumethiazide 1.25 mg/day or 2.5 mg/day and Potassium Chloride Compared with Enalapril 10 mg/day and Amlodipine 5 mg/day in Patients with Mild to Moderate Primary Hypertension: A Multicentre, Randomised, Open Study

By Rasmussen S.  

Clinical Drug Investigation, Vol. 26, Iss. 2, 2006-01 ,pp. : 91-101

Adis International

Access to resources Recommend Favorite

Efficacy and Safety of Inhaled Zanamivir for the Treatment of Influenza in Patients with Asthma or Chronic Obstructive Pulmonary Disease: A Double-Blind, Randomised, Placebo-Controlled, Multicentre Study

By Murphy K.R.  

Clinical Drug Investigation, Vol. 20, Iss. 5, 2000-11 ,pp. : 337-349

Adis International

Access to resources Recommend Favorite

Effect of rosiglitazone/ramipril on preclinical vasculopathy in newly diagnosed, untreated diabetes and IGT patients: 1-year randomised, double-blind, placebo-controlled study

By Rahman Sayeeda   Ismail Aziz   Ismail Shaiful   Naing Nyi   Abdul Rahman Abdul  

European Journal of Clinical Pharmacology, Vol. 63, Iss. 8, 2007-08 ,pp. : 733-741

Springer Publishing Company

Access to resources Recommend Favorite

Influence of Piperine on the Pharmacokinetics of Nevirapine under Fasting Conditions: A Randomised, Crossover, Placebo-Controlled Study

By Kasibhatta Ravisekhar   Naidu M.U.R.  

Drugs in R&D, Vol. 8, Iss. 6, 2007-01 ,pp. : 383-391

Adis International

Access to resources Recommend Favorite